Core Insights - ZimVie Inc. has launched its RealGUIDE Software Suite and Implant Concierge service in Japan, enhancing access to a digital dental implant ecosystem [1][2] - The Japanese dental implant market is significant, representing ZimVie's largest market in the APAC region [1] Product Offerings - RealGUIDE software provides comprehensive tools for precise implant planning, surgical guides, and restorative design, aimed at improving patient care and operational efficiencies [2] - The software is the first complete cloud-based solution of its kind, consisting of multiple modules for thorough diagnosis and advanced design [2] - Implant Concierge is a virtual outsourcing service that simplifies implant treatment planning and guided surgery, designed for high-volume practices [3] Market Opportunity - The rising adoption of dental implants presents a substantial growth opportunity, necessitating more efficient and integrated treatment workflows [4] - Digital dentistry is becoming the new standard in implantology, with ZimVie experiencing strong traction in other markets [4]

Financial Data and Key Metrics Changes - Total revenue for the first quarter of 2025 was $112 million, a decrease of 5.2% in reported rates and a decline of 4.1% in constant currency [18] - Adjusted EBITDA was $17.6 million, translating to a 15.7% adjusted EBITDA margin, reflecting a 41% increase year-over-year [22] - Adjusted earnings per share attributable to continuing operations was $0.27, a 238% increase from $0.08 in the prior year period [23] Business Line Data and Key Metrics Changes - Dental implant sales declined low single digits in Q1, consistent with the overall market performance, but showed improvement in March and April [10][11] - Biomaterials portfolio grew just over 1% during the quarter, reflecting ongoing investments in innovation [13] - Digital dentistry business, excluding oral scanner sales, grew high single digits, with the implant concierge service growing 11% year-over-year [14] Market Data and Key Metrics Changes - U.S. net sales were $65.8 million, a decline of 2.8% compared to the prior year, driven by lower implant sales and oral scanners [19] - International net sales were $46.2 million, a decrease of 8.5% on a reported basis, impacted by lower implant sales and headwinds from various factors [20] - Normalized sales outside the U.S. declined 1.6% in constant currency when accounting for specific headwinds [42] Company Strategy and Development Direction - The company is focused on improving and streamlining manufacturing and supply chain processes while reducing corporate infrastructure [6] - A new Vice President of Americas Sales has been appointed to enhance the sales process and expand the customer base [7] - The company is prioritizing higher-margin implant and digital sales over lower-margin distributed products [8] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the dental market's resilience and the potential for growth in dental implants, which are still under-adopted [66] - The company anticipates continued margin improvement and cash flow generation, aiming to deliver shareholder value [6] - Management reiterated full-year 2025 revenue guidance of $445 million to $460 million, reflecting a 1% decline to 2% growth [25] Other Important Information - The company made a strategic acquisition of a distributor partner in Costa Rica, expected to enhance local market presence and reduce third-party selling costs [16][24] - The company has plans in place to mitigate tariff costs estimated at $3 million per year, largely due to EU-USA tariff rates [6][27] Q&A Session Summary Question: Can you provide more details on the uptick in implant units sold in April? - Management noted that April showed resilience with improved same-store sales and growth in implant units sold, particularly from the new immediate molar implant launch [34] Question: How is pricing trending in the dental market? - Management indicated that the premium implant market has been less price competitive, with selective pricing strategies in place to offset tariff impacts [36][37] Question: What are the reasons for the greater decline in international sales compared to the U.S.? - Management highlighted several headwinds affecting international sales, including foreign exchange impacts and a focus shift away from China [42] Question: What is the current position in the Japanese market? - Management stated that the company has a strong market position in Japan, with the implant concierge expected to drive significant revenue growth [45][47] Question: What actions have been taken to strengthen the supply chain? - Management expressed confidence in manufacturing capabilities and flexibility, having moved significant operations to mitigate tariff risks [58][60]